Safety and efficacy of AGN 203818 in patients with painful diabetic peripheral neuropathy

Trial Profile

Safety and efficacy of AGN 203818 in patients with painful diabetic peripheral neuropathy

Completed
Phase of Trial: Phase II

Latest Information Update: 10 Dec 2007

At a glance

  • Drugs Rezatomidine (Primary)
  • Indications Diabetic neuropathies; Neuropathic pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 Dec 2007 Status changed from recruiting to completed.
    • 24 Oct 2006 Status change
    • 09 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top